Formulation and advantages of furazolidone in liposomal drug delivery systems

European Journal of Pharmaceutical Sciences

Volumn 84, Issue , 2016, Pages 139-145

  Alam, Muhammad Irfan ^a   Paget, Timothy ^a   Elkordy, Amal Ali ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Cholesterol; Drug release; Encapsulation efficiency; Furazolidone; Liposomes; Mucoadhesion

Indexed keywords

CHITOSAN; CHOLESTEROL; FURAZOLIDONE; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; LIPOSOME;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; LIPID BILAYER; LIPID MEMBRANE; LIPOPHILICITY; LIPOSOMAL DELIVERY; MEMBRANE VESICLE; MICROENCAPSULATION; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PH; PKA; PRIORITY JOURNAL; STOMACH MUCUS; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; METABOLISM; SHEEP; STOMACH;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FURAZOLIDONE; HYDROGEN-ION CONCENTRATION; LIPOSOMES; SHEEP; STOMACH;

EID: 84957310368     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.01.017     Document Type: Article

References (34)

1. H. Aliakbar, H.S. Seyyed, S. Rasoul, A. Sonia, and K. Mohammad Low dose furazolidone for eradication of H. pylori instead of clarithromycin: a clinical trial Glob. J. Health Sci. 1916-9744 2015
2. A.K. Ankit, and K.S. Akhlesh Formulation and evaluation of gastroretentive drug deliverysystem of acyclovir as mucoadhesive nanoparticles Int. J. Pharm. Technol. Res. 5 4 2013 1538 1545
3. S. Arora, G. Bisen, and R.D. Budhiraja Mucoadhesive and muco-penetrating delivery systems for eradication of Helicobacter pylori Asian J. Pharm. 6 2012 1 18
4. Y.M. Begum, K. Abbulu, M. Sudhakar, and Aneesa Celecoxib-encapsulated liposomes of long alkyl chain lipids: formulation, characterization and in vitro performance Pharm. Sin. 3 1 2012 117 125
5. A. Bhatia, R. Kumar, and O.P. Katare Tamoxifen in topical liposomes: development, characterization and evaluation J. Pharm. Sci. 7 2 2004 252 259
6. M.J. Blaser, and J.C. Atherton Helicobacter pylori persistence: biology and disease J. Clin. Invest. 113 2004 321 333
7. K. Bowman, and K.W. Leong Chitosan nanoparticles for oral drug and gene delivery Int. J. Nanomedicine 117-128 2006
8. T.L. Cover, and M.J. Blaser Helicobacter pylori in health and disease Gastroenterology 136 2009 1863 1873
9. A. Deniz, A. Sade, F. Severcan, D. Keskin, A. Tezcaner, and S. Banerjee Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics Biosci. Rep. 30 5 2010 365 373
10. H. Du, M. Liu, X. Yang, and G. Zhai The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery Drug Discov. Today 2016 10.1016/j.drudis.2015.03.002 (in press)
11. G.M. El Zaafarany, G.A.S. Awad, S.M. Holayel, and N.D. Mortada Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery Int. J. Pharm. 397 2010 164 172
12. F.S. Habib, E.A. Fouad, M.S. Abdel-Rhaman, and D. Fathalla Liposomes as an ocular delivery system of fluconazole: in-vitro studies Acta Ophthalmol. (Copenh) 88 8 2010 901 904
13. A. Haeria, B. Alinaghiana, M. Daeihameda, and S. Dadashzadeha Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors Iran. J. Pharm. Res. 13 Suppl. 2014 3 14
14. H.K. Han, H.J. Shin, and D.H. Ha Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system Eur. J. Pharm. Sci. 46 5 2012 500 507
15. S. Hidekazu, N. Toshihiro, and H. Toshifumi Helicobacter pylori eradication therapy Future Microbiol 2015 639 648
16. R. Jayakumar, D. Menon, K. Manzoor, S.V. Nair, and H. Tamura Biomedical applications of chitin and chitosan based nanomaterials - a short review Carbohydr. Polym. 82 2 2010 227 232
17. A. Jesorka, and O. Orwar Liposomes: technologies and analytical applications Annu Rev Anal Chem (Palo Alto, Calif) 1 2008 801 832
18. P.R. Karn, Z. Vanić, I. Pepi, and N. Skalko-Basnet Mucoadhesive liposomal delivery systems: the choice of coating material Drug Dev. Ind. Pharm. 37 4 2011 482 488
19. S.K. Lai, Ying-Ying, and J. H. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. 2009 158 171
20. M. Laura, B. Ensigna, R. Conea, and J. Hanes Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 2012 557 570
21. N. Li, C. Zhuang, M. Wang, X. Sun, S. Nie, and W. Pan Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int. J. Pharm. 379 1 2009 131 138
22. M. Liu, J. Zhang, W. Shan, and Y. Huang Developments of mucus penetrating nanoparticles Asian J. Pharm. Sci. 275-282 2015
23. P. Luo Izon q nano training modules 2014 The Oxford Science Park, Magdalen Centre Robert Robinson Avenue, Oxford, OX4 4GA, United Kingdom (www.izon.com. Accessed 25/06/2014)
24. M.M. Nounou, L.K. El-khordagui, and N. Khalafallah Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles Acta Pol. Pharm. 62 5 2005 369 379
25. E.A. O'Gara, D.J. Maslin, A.M. Nevill, and D.J. Hill The effect of simulated gastric environments on the anti-Helicobacter activity of garlic oil J. Appl. Microbiol. 104 5 2008 1324 1331
26. J. Parmentier, F.J. Hartmann, and G. Fricker In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules Eur. J. Pharm. Biopharm. 76 3 2010 394 403
27. P. Rojanapanthu, N. Sarisuta, K. Chaturon, and K. Kra-isintu Drug Dev. Ind. Pharm. 29 2013 31
28. M.B. Sankaram, and T.E. Thompson Interaction of cholesterol with various glycerophospholipids and sphingomyelin Biochemistry 29 1990 10670 10675
29. D. Scott, K.M. Weeks, and G. Sachs The life and death of Helicobacter pylori Gut 43 1998 56 60
30. G. Shazly, T. Nawroth, and P. Langguth Comparison of dialysis and dispersion methods for in vitro release determination of drugs from multilamellar liposomes Dissolut. Technol. 7-10 2008
31. I.M. Torres, E.B. Bento, L.C. Almeida, and L.Z. Carvalho Martins Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains Braz. J. Microbiol. 2012 984 992
32. N. Venkateswaramurthy, R. Sambathkumar, M. Vijayabaskaran, and P. Perumal Formulation and in vitro evaluation of furazolidone mucoadhesive microspheres Int. J. Pharm. Pharm. Sci. 2 3 2010 104 106
33. J.R. Warren, and B.J. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 342 1983 1273 1275
34. X. Zhu, D. Zhou, S. Guan, P. Zhang, Z. Zhang, and Y. Huang Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics J. Mater. Sci. Mater. Med. 23 4 2012 983 990